Wolfgang A Tome

Title: Innovations of Wolfgang A. Tome in Tumor Targeting Agents

Introduction

Wolfgang A. Tome is a prominent inventor based in Madison, WI (US), known for his significant contributions to the field of medical imaging and therapy. He holds a total of 6 patents that focus on innovative solutions for detecting and treating solid tumors. His work has the potential to greatly enhance the effectiveness of cancer therapies.

Latest Patents

One of Wolfgang A. Tome's latest patents involves long-lived gadolinium-based tumor-targeted imaging and therapy agents. These agents consist of alkylphosphocholine analogs that incorporate a chelating moiety, which is chelated to gadolinium. The compounds are designed to detect solid tumors and provide therapeutic treatment. In imaging applications, the gadolinium emits signals that can be detected using magnetic resonance imaging. In therapeutic contexts, it emits tumor-targeting charged particles when exposed to epithermal neutrons.

Career Highlights

Wolfgang A. Tome is associated with the Wisconsin Alumni Research Foundation, where he has been instrumental in advancing research in tumor targeting technologies. His innovative approaches have garnered attention in the medical community, particularly for their potential to improve cancer detection and treatment.

Collaborations

Wolfgang has collaborated with notable colleagues, including Jamey Paul Weichert and Anatoly Pinchuk. Their combined expertise has contributed to the development of groundbreaking technologies in the field of medical imaging and therapy.

Conclusion

Wolfgang A. Tome's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents reflect a commitment to improving patient outcomes through advanced imaging and therapeutic techniques.